arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Inogen, Inc

INGN Health Care Industrial Specialties
$5.42
Today
as of Sep 4, 16:50 ET
Last 30 days -15.58% Jul 28 → Sep 04
$5.20 $5.66 $6.12 $6.59 $7.05 Jul 28 Aug 05 Aug 12 Aug 20 Aug 27 Sep 04
Open
$5.40
High
$5.47
Low
$5.37
Volume
$216,594
Avg Vol
$251,279
Mkt Cap
$154M
P/E (TTM)
—
Beta
—
52w High
$9.13
52w Low
$5.29
Div Yield
—
Shares Out
$27M

Recent Press Releases & News last 60 days · 13 items

Aug 21 · 15:46 Zacks
Here's Why You Should Retain Inogen Stock in Your Portfolio for Now
Aug 17 · 19:36 Insider Monkey
Inogen (INGN) Cuts Guidance Even As Profitability Climbs
Aug 14 · 15:03 Motley Fool
Inogen (INGN) Q2 2026 Earnings Call Transcript
▸ Show all 13 press releases & news Free account →

Overview

52-week range
$5.29
$9.13
3% of range
Avg surprise (last 3)
+19.6%
Avg reaction (last 2)
+1.3%
100% positive
Latest IV / EM
118%
EM ±18.5% · $5 · Sep 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-1.97$-1.51$-1.05$-0.60$-0.14 Actual $-0.88Actual $-0.42Actual $-1.97Actual $-0.62Actual $-0.24Actual $-0.25Actual $-0.25Est $-0.52Actual $-0.15Est $-0.22Actual $-0.20Actual $-0.30Est $-0.24Actual $-0.14 MarJunSepMarJunSepMar/2025Jun/2025SepMar/2026Jun
Revenue vs Net Income Revenue Net income
$-8M$19M$46M$73M$100M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $-0.14 — — — — financials
Thu May 7, 2026Mar/2026 $-0.30 $-0.24 -25.0% -20.0% +1.1% earnings
Tue Sep 30, 2025Sep 2025 $-0.20 — — — — financials
Thu Aug 7, 2025Jun/2025 $-0.15 $-0.22 +31.8% — — earnings
Wed May 7, 2025Mar/2025 $-0.25 $-0.52 +51.9% — +1.4% earnings
Mon Sep 30, 2024Sep 2024 $-0.25 — — — — financials
Sun Jun 30, 2024Jun 2024 $-0.24 — — — — financials
Sun Mar 31, 2024Mar 2024 $-0.62 — — — — financials
Sat Sep 30, 2023Sep 2023 $-1.97 — — — — financials
Fri Jun 30, 2023Jun 2023 $-0.42 — — — — financials
Fri Mar 31, 2023Mar 2023 $-0.88 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$95M$85M—$92M$92M$82M—$89M
Cost of revenue$52M$47M—$51M$51M$46M—$47M
Gross profit$43M$38M—$41M$41M$36M—$41M
Operating income$-5M$-9M—$-7M$-6M$-8M—$-8M
Net income$-4M$-8M—$-5M$-4M$-6M—$-6M
EPS (diluted)$-0.14$-0.30—$-0.20$-0.15$-0.25—$-0.25

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$87M$93M$104M$106M$104M$119M$114M$106M
Inventory$29M$25M$26M$25M$24M$26M$25M$23M
Total current assets$194M$191M$198M$204M$203M$201M$185M$193M
Total assets$286M$286M$299M$307M$312M$308M$296M$306M
Long-term debt————————
Total liabilities$111M$103M$106M$110M$113M$110M$122M$121M
Total equity$175M$183M$192M$197M$199M$198M$174M$185M

Implied volatility — last 90 days

93%281%469%657%845% Jun 07 — IV 253% · EM ±35.1%Jun 08 — IV 350% · EM ±46.2%Jun 09 — IV 358% · EM ±44.9%Jun 10 — IV 270% · EM ±31.9%Jun 11 — IV 436% · EM ±48.1%Jun 12 — IV 344% · EM ±35.2%Jun 15 — IV 728% · EM ±52.6%Jun 16 — IV 806% · EM ±47.6%Jun 17 — IV 846% · EM ±35.3%Jun 19 — IV 169% · EM ±37.4%Jun 22 — IV 175% · EM ±36.5%Jun 23 — IV 164% · EM ±33.6%Jun 24 — IV 151% · EM ±30.3%Jun 25 — IV 188% · EM ±36.9%Jun 30 — IV 225% · EM ±38.8%Jul 01 — IV 176% · EM ±29.3%Jul 02 — IV 192% · EM ±31.1%Jul 03 — IV 199% · EM ±31.1%Jul 06 — IV 211% · EM ±29.2%Jul 07 — IV 191% · EM ±25.2%Jul 08 — IV 271% · EM ±33.9%Jul 09 — IV 279% · EM ±32.9%Jul 10 — IV 346% · EM ±38.2%Jul 13 — IV 430% · EM ±35.9%Jul 14 — IV 535% · EM ±38.7%Jul 15 — IV 581% · EM ±34.3%Jul 16 — IV 701% · EM ±29.3%Jul 20 — IV 165% · EM ±39.1%Jul 21 — IV 201% · EM ±46.7%Jul 22 — IV 149% · EM ±34.2%Jul 23 — IV 139% · EM ±31.2%Jul 24 — IV 239% · EM ±52.8%Jul 27 — IV 139% · EM ±28.9%Jul 28 — IV 128% · EM ±26.1%Jul 29 — IV 175% · EM ±35.0%Jul 30 — IV 129% · EM ±25.3%Jul 31 — IV 134% · EM ±25.6%Aug 03 — IV 147% · EM ±26.1%Aug 04 — IV 123% · EM ±21.3%Aug 05 — IV 94% · EM ±15.6%Aug 06 — IV 172% · EM ±27.8%Aug 07 — IV 333% · EM ±52.1%Aug 10 — IV 270% · EM ±37.4%Aug 11 — IV 263% · EM ±34.7%Aug 12 — IV 268% · EM ±33.6%Aug 13 — IV 335% · EM ±39.6%Aug 14 — IV 291% · EM ±32.2%Aug 17 — IV 451% · EM ±37.7%Aug 18 — IV 358% · EM ±25.9%Aug 19 — IV 537% · EM ±31.7%Aug 20 — IV 577% · EM ±24.1%Aug 24 — IV 135% · EM ±28.2%Aug 25 — IV 128% · EM ±26.2%Aug 26 — IV 130% · EM ±26.1%Aug 27 — IV 125% · EM ±24.5%Aug 28 — IV 128% · EM ±24.5%Aug 31 — IV 142% · EM ±25.1%Sep 01 — IV 131% · EM ±22.5%Sep 02 — IV 117% · EM ±19.5%Sep 03 — IV 136% · EM ±22.0%Sep 04 — IV 118% · EM ±18.4%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,148.00-0.1%
JNJ
Johnson & Johnson
$671.0B $275.71+0.2%
ABBV
AbbVie Inc.
$430.9B $256.50+0.1%
MRK
Merck & Company, Inc.
$317.1B $150.33+0.0%
PM
Philip Morris International Inc
$299.3B $182.53+0.0%
NVS
Novartis AG
$297.9B $155.11-3.0%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in